Altered expression of ezrin in esophageal squamous cell carcinoma

Journal of Histochemistry and Cytochemistry

Volumn 54, Issue 8, 2006, Pages 889-896

  Zeng, Hongmei ^a   Xu, Liyan ^a,b   Xiao, Dawei ^c   Zhang, Haihua ^a   Wu, Xianying ^a   Zheng, Ruiming ^a   Li, Qiaoshan ^a   Niu, Yongdong ^a   Shen, Zhongying ^a   Li, Enmin ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b BEIJING UNIVERSITY OF TECHNOLOGY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Esophageal carcinoma; Ezrin; Immunohistochemistry; Proliferating cell nuclear antigen; Real time RT PCR

Indexed keywords

CYCLINE; EZRIN; MOESIN; RADIXIN;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CELL MOTILITY; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTEIN TRANSPORT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 33746286920     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.5A6881.2006     Document Type: Article

References (28)

1. Autero M, Heiska L, Ronnstrand L, Vaheri A, Gahmberg CG, Carpen O (2003) Ezrin is a substrate for Lck in T cells. FEBS Lett 535:82-86
2. Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3:586-599
3. Bretscher A, Reczek D, Berryman M (1997) Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J Cell Sci 110:3011-3018
4. Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M (2005) The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 7:R365-373
5. Gautreau A, Louvard D, Arpin M (2002) ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr Opin Cell Biol 14:104-109
6. Geiger KD, Stoldt P, Schlote W, Derouiche A (2000) Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol 157:1785-1793
7. Guan XQ, Wang CJ, Li YY (2002) Effects of ezrin on differentiation and adhesion of hepatocellular carcinoma. Ai Zheng 21:281-284
8. Hiscox S, Jiang WG (1999) Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/β-catenin. J Cell Sci 112:3081-3090
9. Huang T, You Y, Spoor MS, Richer EJ, Kudva W, Paige RC, Seiler MP, et al. (2003) Foxj1 is required for apical localization of ezrin in airway epithelial cells. J Cell Sci 116:4935-4945
10. Hunter KW (2004) Ezrin, a key component in tumor metastasis. Trends Mol Med 10:201-204
11. Ilmonen S, Vaheri A, Asko-Seljavaara S, Carpen O (2005) Ezrin in primary cutaneous melanoma. Mod Pathol 18:503-510
12. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, et al. (2004) The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10:182-186
13. Kimos MC, Wang S, Borkowski A, Yang GY, Yang CS, Perry K, Olaru A, et al. (2004) Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression. Int J Cancer 111:415-417
14. Louvet-Vallée S (2000) ERM proteins: from cellular architecture to cell signaling. Biol Cell 92:305-316
15. Lozupone F, Lugini L, Matarrese P, Luciani F, Federici C, Iessi E, Margutti P, et al. (2004) Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin. J Biol Chem 279:9199-9207
16. Moilanen J, Lassus H, Leminen A, Vaheri A, Butzow R, Carpen O (2003) Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. Gynecol Oncol 90:273-281
17. Parlato S, Giammarioli AM, Logozzi M, Lozupone F, Matarrese P, Luciani F, Falchi M, et al. (2000) CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J 19:5123-5134
18. Roy C, Martin M, Mangeat P (1997) A dual involvement of the amino-terminal domain of ezrin in F- and G-actin binding. J Biol Chem 272:20088-20095
19. Saotome I, Curto M, McClatchey AI (2004) Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell 6:855-864
20. Shen ZY, Chen MH, Shen J, Cai WJ, Zeng Y (2002) Progressive transformation of immortalized esophageal epithelial cells. World J Gastroenterol 8:976-981
21. Shen ZY, Xu LY, Chen MH, Li EM, Li JT, Wu XY, Zeng Y (2003) Upregulated expression of ezrin and invasive phenotype in malignantly transformed esophageal epithelial cells. World J Gastroenterol 9:1182-1186
22. Srivastava J, Elliott BE, Louvard D, Arpin M (2005) Src-dependent ezrin phosphorylation in adhesion-mediated signaling. Mol Biol Cell 16:1481-1490
23. Tokunou M, Niki T, Saitoh Y, Imamura H, Sakamoto M, Hirohashi S (2000) Altered expression of the ERM proteins in lung adenocarcinoma. Lab Invest 80:1643-1650
24. Turunen O, Wahlstrom T, Vaheri A (1994) Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol 126:1445-1453
25. Tynninen O, Carpen O, Jaaskelainen J, Paavonen T, Paetau A (2004) Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol 30:472-477
26. Weng WH, Ahlen J, Astrom K, Lui WO, Larsson C (2005) Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 11:6198-6204
27. Yang HS, Hinds PW (2003) Increased ezrin expression and activation by CDK5 coincident with acquisition of the senescent phenotype. Mol Cell 11:1163-1176
28. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G (2004) Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 10:175-181